Genentech: Avastin colon study continuing – Bizjournals.com
Beauty and Health · Tags:
|
Genentech: Avastin colon study continuing
Bizjournals.com - Genentech Inc. said a Phase III study of Avastin against early-stage colon cancer will continue as planned. The announcement – and its timing – is important for South San Francisco-based Genentech (NYSE: DNA) and might figure into Roche Holding’s … UPDATE 1-Avastin trial in early bowel cancer to continue Genentech to Continue Avastin Trial |
Comments
Leave a comment!